Optiver Holding B.V. Grifols Sa Transaction History

Optiver Holding B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $26,412 - $32,423	-2,547 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $459,941 - $524,145	-27,674 Reduced 91.57%	2,547 $44,000
Q1 2021 May 20, 2021	SELL	$15.15 - $19.78 $20.8 Million - $27.1 Million	-1,370,297 Reduced 97.84%	30,221 $511,000
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $21.2 Million - $27.7 Million	1,400,518 New	1,400,518 $24.2 Million

162

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.